Not for human use. No drug license, no aseptic validation, no batch release authority. Purity is supplier-asserted.
Good manufacturing practice, often for a narrow scope. Frequently fill-and-finish rather than end-to-end.
Holds a national drug manufacturing license. Synthesises the active ingredient, makes the finished sterile product, and cannot ship without formal QA release. This is the tier supplying Med Plug RX.
Most competing supply is Tier One at worst and Tier Two at best. Batch release is a legal constraint, not a policy — product without it may not enter shipment.
Gold marks the steps where a fill-and-finish operation would be receiving material rather than making it.
Aseptic filling under HEPA filtration, unidirectional airflow and barrier isolators.
Sterilizing-grade membrane, integrity tested pre-use and post-use.
Purity verified per lot, with a certificate of analysis supplied.
A licensed manufacturer cannot release a batch on a policy or a promise. Release is a legal act, signed by qualified persons against the tested record of that lot.
Product is examined against specification before it reaches a buyer, not after a complaint. Domestic assembly removes an international leg and cuts custody transfers under temperature control.
Premixed liquids ship at 2–8°C in qualified insulated packaging with data loggers, evaluated routes and defined transport limits.
This site does not represent the finished drug product as manufactured in the United States. Manufacturer identity, address and license numbers are redacted pending NDA.
The certification package, manufacturer identity and the independent laboratory report are released to verified physician accounts under NDA.
